Journal article
A multicentre, prospective, randomized, controlled study to evaluate the use of a fibrin sealant as an adjunct to sutured dural repair.
- Abstract:
- Background. Obtaining intra-operative watertight closure of the dura is considered important in reducing post-operative cerebrospinal fluid (CSF) leak. The purpose of this study was to evaluate a fibrin sealant as an adjunct to sutured dural repair to obtain intra-operative watertight closure in cranial neurosurgery. Methods. This randomized, controlled multicenter study compared a fibrin sealant (EVICEL(®) Fibrin Sealant [Human]) to sutured dural closure (Control). Subjects underwent supratentorial or posterior fossa procedures. Following primary dural repair by sutures, the closure was evaluated for intra-operative CSF leak by moderately increasing the intracranial pressure. If present, subjects were randomized to EVICEL(®) or additional sutures (2:1 ratio), stratified by surgical approach. Following treatment, subjects were successful if no CSF leaks were present during provocative challenge. Safety was assessed to 30 days post-surgery, including incidence of CSF leakage. Results. One hundred and thirty-nine subjects were randomized: 89 to EVICEL(®) and 50 to Control. Intra-operative watertight closure was achieved in 92.1% EVICEL(®)-treated subjects versus 38.0% controls; a treatment difference of 54.1% (p < 0.001). The treatment differences in the supratentorial and posterior fossa strata were 49.1% and 75.7%, respectively (p < 0.001). The incidence of adverse events was similar between treatment groups. No deaths or unexpected serious adverse drug reactions were reported. CSF leakage within 30 days post-operatively was 2.2% and 2.0% in EVICEL(®) and control groups, respectively. In addition, 2 cases of CSF rhinorrhoea were observed in the EVICEL(®) group. Although not associated with the suture line where EVICEL(®) was applied, when combined with the other CSF leaks, the observed leak rate in the EVICEL(®) group was 4.5%. Conclusions. These results indicate that EVICEL(®) is effective as an adjunct to dural sutures to provide watertight closure of the dura mater in cranial surgery. The study confirmed the safety profile of EVICEL(®).
Actions
Access Document
- Publisher copy:
- 10.3109/02688697.2014.948808
Authors
- Journal:
- British journal of neurosurgery More from this journal
- Pages:
- 1-7
- Publication date:
- 2014-08-01
- DOI:
- EISSN:
-
1360-046X
- ISSN:
-
0268-8697
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:480094
- UUID:
-
uuid:1b946569-9fb7-48d6-946c-ff9ae50ac3ba
- Local pid:
-
pubs:480094
- Source identifiers:
-
480094
- Deposit date:
-
2014-09-18
- ARK identifier:
Terms of use
- Copyright date:
- 2014
If you are the owner of this record, you can report an update to it here: Report update to this record